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Our diet includes a wide variety
of different molecules. Many of
these molecules are broken
down completely and used to
generate the metabolic energy
that powers our cells. Others are
disassembled piece-by-piece and
recycled to build our own 
proteins and nucleic acids. The
ones that are left over are 
broken down and discarded.
Xanthine oxidoreductase, shown
here from PDB entry 1fo4, is
the last stop for extra purine
nucleotides (ATP and GTP) in
our cells. Purines are broken
down in several steps, ultimately
yielding uric acid, which is
excreted from the body. 
Extracting Electrons
Xanthine  oxidoreductase  shuffles  electrons
around,  so  it  includes  several  specialized
molecular tools for handling electrons. At
one end of the enzyme, an active site
binds  to  the  purine  substrate  and
adds a hydroxyl group to it. This
tricky reaction is performed by a
cofactor that includes a molybde-
num atom. Electrons are extracted
in  the  process  and  a  string  of
iron-sulfur clusters funnel the elec-
trons from the purine active site to a
site on the opposite side of the enzyme,
which ultimately transfers the electrons to
NAD or oxygen.
Supporting Roles
Xanthine  oxidoreductase  is  found
inside cells, where it performs its
role  in  purine  degradation.
However,  xanthine  oxidoreductase
is also plentiful in milk, which has
made  it  a  popular  enzyme  for  study
since it is very easy to isolate and purify.
In milk, it is thought to play several roles. In
its reaction with oxygen, it releases hydrogen
peroxide, which is a very reactive substance.
This  may  help  give  milk  its  antibacterial
properties. It also plays a key role in the secre-
tion of fat globules as milk is being produced.
Surprisingly, this role appears to depend on
the  interaction  of  xanthine  oxidoreductase
with other proteins in the mammary gland
cell  membranes,  and  not  on  the  catalytic
activity of the enzyme.
Painful Purines
Inhibitors  of  xanthine  oxidoreductase  are
useful for treating gout. Gout is a painful dis-
ease  where  crystals  of  uric  acid  collect  in
joints  (in  particular,  the  big  toe),  causing
painful  inflammation. The  conditions  that
lead to gout are still a bit of a mystery, but it
seems to be connected to high levels of uric
acid in the blood. This, in turn, can be caused
by a diet that is rich in purines, including
such foods as anchovies and sardines, liver,
asparagus and mushrooms. Drugs that block
xanthine oxidoreductase, such as allopurinol,
reduce the production of uric acid, reducing
the levels in the blood.
Total Destruction
Most organisms have additional enzymes that
take the destruction of purines further. Most
have  urate  oxidase  (shown  on  the  reverse
from  PDB  entry  1r4u)  and  a  few  other
enzymes that ultimately produce allantoin, a
molecule that is more soluble and easier to
excrete than uric acid. Some organisms go
even further and break it all the way down
into ammonia and carbon dioxide. Strangely,
1fo4RCSB Protein Data Bank
The Protein Data Bank (PDB) is the
single worldwide repository for the 
processing and distribution of 3D
structure data of large molecules of
proteins and nucleic acids. The RCSB
PDB is operated by Rutgers, The State
University of New Jersey and the San
Diego Supercomputer Center and the
Skaggs School of Pharmacy and
Pharmaceutical Sciences at the University
of California, San Diego–two members
of the Research Collaboratory for
Structural Bioinformatics (RCSB). 
It is supported by funds from the
National Science Foundation, the
National Institute of General Medical
Sciences, the Office of Science,
Department of Energy, the National
Library of Medicine, the National
Cancer Institute, the National Institute
of Neurological Disorders and Stroke
and the National Institute of Diabetes
& Digestive & Kidney Diseases. 
The RCSB PDB is a member of
the worldwide PDB 
(wwPDB; www.wwpdb.org).
References: 
1fo4, 1fiq: C. Enroth, B. T. Eger, K. Okamoto, T.
Nishino, T. Nishino, E. F. Pai (2000) Crystal struc-
tures of bovine milk xanthine dehydrogenase and xan-
thine oxidase: structure-based mechanism of conver-
sion. Proc.Natl.Acad.Sci.USA 97, 10723-10728
1r4u:  P.  Retailleau,  N.  Colloc`h,  D.  Vivares,  F.
Bonnete,  B.  Castro,  M.  El-Hajji,  J.  P.  Mornon,  G.
Monard, T. Prange (2004) Complexed and ligand-free
high-resolution structures of urate oxidase (Uox) from
Aspergillus  flavus:  a  reassignment  of  the  active-site
binding mode. Acta Crystallogr.,Sect.D 60, 453-462
1jrp: J. J. Truglio, K. Theis, S. Leimkuhler, R. Rappa,
K. V. Rajagopalan, C. Kisker (2002) Crystal struc-
tures of the active and alloxanthine-inhibited forms of
xanthine dehydrogenase from Rhodobacter capsula-
tus. Structure 10: 115-125
XANTHINE OXIDOREDUCTASE
Topics for Further Exploration
1. Molybdenum is a rare element, used by 
only a few enzymes. Can you find other
examples  in  the  PDB?  Do  they  use  a
similar cofactor to hold and activate the
molybdenum ion?
2. PDB entry 3eub includes xanthine oxidore-
ductase with thesubstrate xanthine bound
in the active site. How did the researchers
obtain  this  structure  without  having  the
enzyme make its chemical change? 
Exploring the Structure
Xanthine  oxidoreductase  is  actually  two
enzymes  in  one.  Early  in  the  study  of  the
enzyme,  scientists  purified  a  form  that  uses
NAD and a different form that uses oxygen.
Scientists  originally  thought  they  were  two
different enzymes and gave them two names:
xanthine dehydrogenase and xanthine oxidase.
However, when they finally got a look at the
amino  acid  sequence,  both  enzymes  turned
out to be the same. The forms differ in two
ways. First, there are several disulfide bridges
in the enzyme: if they are formed, the enzyme
acts  as  the  oxidase,  if  they  are  broken,  the
enzyme acts as the dehydrogenase. Second, the
enzyme may be clipped by proteases to convert
it  permanently  to  the  oxidase  form.  Two
examples are shown here: the dehydrogenase
form is shown on the left from PDB entry
1fo4  and  the  proteolyzed  oxidase  form  is
shown on the right from PDB entry 1fiq. One
of the sites of cleavage is shown in white with
a star. The last step in the electron transfer
chain  is  an  FAD  group,  shown  here  in
turquoise.  In  the  dehydrogenase  form,  this
transfers electrons to NAD, but in the oxidase
form, a loop of protein, shown here in bright
red,  covers  the  FAD,  excluding  NAD  but
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our cells have a mutated version of the urate
oxidase  gene  that  is  inactive.  Scientists  have
postulated that this gene was mutated during
the evolution of humans to provide us with a
benefit  for  aging.  Uric  acid  is  a  powerful
antioxidant, and the higher levels in our blood,
caused by the evolutionary loss of urate oxi-
dase, may help protect us from oxygen damage
over our long lifespans.
allowing smaller oxygen molecules to accept
electrons from FAD.
Several xanthine oxidoreductase structures in
the PDB also show the details of ligand bind-
ing in the enzyme. For instance, PDB entry
1jrp shows  the  enzyme  with  a  purine-like
inhibitor bound to the molybdenum cofactor. 
1r4u